Denne siden ble automatisk oversatt og nøyaktigheten av oversettelsen er ikke garantert. Vennligst referer til engelsk versjon for en kildetekst.

Social Media Perceptions Among Young Adults With Cancer - Online Experiment 1 (SIYA MOS1)

4. november 2026 oppdatert av: UNC Lineberger Comprehensive Cancer Center

Young adults with cancer experience more loneliness than their non-cancer peers or older cancer survivors. Positive psychology interventions may increase social connectedness; however, evidence-based interventions should be tailored to young adults with cancer and designed for social media. This study conducted an online experiment with young adults with cancer (ages 22-39) to optimize intervention messages.

Studieoversikt

Detaljert beskrivelse

To examine how message types and personal stories influence reactions, the study used a mixed between-within online experiment. The researchers hypothesized that four message types (connected peer advocates, lonely peer advocates, cancer peers, and clinicians) would lead to greater perceived message effectiveness in encouraging positive in-person social interactions and stronger intended message reactions compared with control messages (H1). They also hypothesized that including a personal story (cancer-related or general) would improve perceived message effectiveness and intended message reactions (H2). Unintended message reactions were also explored.

Studietype

Intervensjonell

Registrering (Faktiske)

505

Fase

  • Ikke aktuelt

Kontakter og plasseringer

Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.

Studiesteder

    • North Carolina
      • Chapel Hill, North Carolina, Forente stater, 27599
        • University of North Carolina at Chapel Hill

Deltakelseskriterier

Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.

Kvalifikasjonskriterier

Alder som er kvalifisert for studier

22 år til 39 år (Voksen)

Tar imot friske frivillige

Nei

Kjønn som er kvalifisert for studier

Alle

Beskrivelse

Inclusion Criteria:

  • Participants must be 22-39 years old at the time of the study
  • Participants must have received a cancer diagnosis at any point between ages 15-39
  • Participants must self-report low-to-moderate psychosocial quality of life (QOL), defined as an average rating of 4 or lower on the National Institutes of Health's (NIH's) validated 2-item Patient Reported Outcomes Measurement Information System (PROMIS) global mental health scale (two 5-point items)
  • Participants must use social media

Exclusion Criteria:

  • None

Studieplan

Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.

Hvordan er studiet utformet?

Designdetaljer

  • Primært formål: Annen
  • Tildeling: Randomisert
  • Intervensjonsmodell: Parallell tildeling
  • Masking: Ingen (Open Label)

Våpen og intervensjoner

Deltakergruppe / Arm
Intervensjon / Behandling
Eksperimentell: Connected advocate advice

Participants viewed five social media-based messages consisting of photographs of peers who are cancer advocates who have successfully created social connections and captions with advice for having more in person connections.

Participants were randomized to 1 of 5 message conditions.

Eksperimentell: Lonely advocate advice

Participants viewed five social media-based messages consisting of photographs of peers who are cancer advocates who are experiencing loneliness but still try to have social connections and captions with advice for having more in person connections.

Participants were randomized to 1 of 5 message conditions.

Eksperimentell: Peer-to-peer sharing

Participants viewed five social media-based messages consisting of peer-to-peer sharing about connecting with others and captions with advice for having more in person connections.

Participants were randomized to 1 of 5 message conditions

Eksperimentell: Clinician advice

Participants viewed five social media-based messages consisting of photographs of clinicians and captions with advice for having more in person connections.

Participants were randomized to 1 of 5 message conditions.

Eksperimentell: Control messages

Participants were randomized to 1 of 5 message conditions.

Participants were randomized to 1 of 5 message conditions.

Hva måler studien?

Primære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Perceived Message Effectiveness (Single-Item Self-Report, 5-Point Scale)
Tidsramme: Baseline, Up to 1 hour

After viewing each of 5 social media posts, participants answered one item: "How much does this post make you want to connect in person with people you barely know more often?" Response options ranged from 1 (not at all) to 5 (very much); higher scores indicate greater perceived message effectiveness. Ratings were compared across experimental conditions and message types.

Baseline, Up to 1 hour

Sekundære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Positive Affect (Single-Item Self-Report, 5-Point Scale)
Tidsramme: Baseline, Up to 1 hour

After viewing each of 5 social media posts, participants answered one item: "How good does viewing this post make you feel?" Response options ranged from 1 (not at all) to 5 (very much); higher scores indicate greater positive affect. Ratings were compared across experimental conditions and message types.

Baseline, Up to 1 hour
Perceived Social Presence (Single Item Adapted From Lazard et al., 2020; 5-Point Scale)
Tidsramme: Baseline, Up to 1 hour

After viewing each of 5 social media posts, participants answered one item: "When viewing this post, how much do you feel as if someone is talking to you?" Response options ranged from 1 (not at all) to 5 (very much); higher scores indicate greater perceived social presence. Ratings were compared across experimental conditions and message types.

Baseline, Up to 1 hour
Message Relevance (Single Item Adapted From Jensen et al., 2024; 5-Point Scale)
Tidsramme: Baseline, Up to 1 hour

After viewing each of 5 social media posts, participants answered one item: "How relevant is this post to you?" Response options ranged from 1 (not at all) to 5 (very much); higher scores indicate greater perceived relevance. Ratings were compared across experimental conditions and message types.

Baseline, Up to 1 hour
Attention (Single Item Adapted From Sutfin et al., 2019; 5-Point Scale)
Tidsramme: Baseline, Up to 1 hour

After viewing each of 5 social media posts, participants answered one item: "How much does this post grab your attention?" Response options ranged from 1 (not at all) to 5 (very much); higher scores indicate greater attention. Ratings were compared across experimental conditions and message types.

Baseline, Up to 1 hour
Perceived Authenticity (Single-Item Self-Report, 5-Point Scale)
Tidsramme: Baseline, Up to 1 hour

After viewing each of 5 social media posts, participants answered one item: "How much do you think this post shares a real perspective?" Response options ranged from 1 (not at all) to 5 (very much); higher scores indicate greater perceived authenticity. Ratings were compared across experimental conditions and message type.

Baseline, Up to 1 hour

Andre resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Negative Affect, Unintended Reaction (Single-Item Self-Report, 5-Point Scale)
Tidsramme: Baseline, Up to 1 hour

After viewing each of 5 social media posts, participants answered one item: "How bad does viewing this post make you feel?" Response options ranged from 1 (not at all) to 5 (very much); higher scores indicate greater negative affect (a less favorable reaction). Ratings were compared across experimental conditions and message types.

Baseline, Up to 1 hour
Reactance, Unintended Reaction (Single Item Adapted From Hall et al., 2017; 5-Point Scale)
Tidsramme: Baseline, Up to 1 hour

After viewing each of 5 social media posts, participants answered one item: "How much does this post annoy you?" Response options ranged from 1 (not at all) to 5 (very much); higher scores indicate greater reactance (a less favorable reaction). Ratings were compared across experimental conditions and message types.

Baseline, Up to 1 hour

Samarbeidspartnere og etterforskere

Det er her du vil finne personer og organisasjoner som er involvert i denne studien.

Samarbeidspartnere

Etterforskere

  • Hovedetterforsker: Allison J Lazard, PhD, UNC Lineberger Comprehensive Cancer Center

Publikasjoner og nyttige lenker

Den som er ansvarlig for å legge inn informasjon om studien leverer frivillig disse publikasjonene. Disse kan handle om alt relatert til studiet.

Studierekorddatoer

Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.

Studer hoveddatoer

Studiestart (Faktiske)

27. mai 2025

Primær fullføring (Faktiske)

23. juli 2025

Studiet fullført (Faktiske)

23. juli 2025

Datoer for studieregistrering

Først innsendt

27. oktober 2026

Først innsendt som oppfylte QC-kriteriene

4. november 2026

Først lagt ut (Faktiske)

10. november 2026

Oppdateringer av studieposter

Sist oppdatering lagt ut (Faktiske)

10. november 2026

Siste oppdatering sendt inn som oppfylte QC-kriteriene

4. november 2026

Sist bekreftet

1. november 2026

Mer informasjon

Begreper knyttet til denne studien

Ytterligere relevante MeSH-vilkår

Andre studie-ID-numre

  • SIYA MOS1 Online Experiment 1
  • R01CA276176 (U.S. NIH-stipend/kontrakt)

Plan for individuelle deltakerdata (IPD)

Planlegger du å dele individuelle deltakerdata (IPD)?

NEI

Legemiddel- og utstyrsinformasjon, studiedokumenter

Studerer et amerikansk FDA-regulert medikamentprodukt

Nei

Studerer et amerikansk FDA-regulert enhetsprodukt

Nei

Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .

Abonnere